Skip to main content
. 2019 Nov 8;9:1193. doi: 10.3389/fonc.2019.01193

Figure 4.

Figure 4

Recurrence-free survival for low risk patients with true negative and false negative groups and for high risk patients with true positive and false positive IMLN groups. Recurrence-free survival for low risk patients (A) with true negative and false negative groups and for high risk patients (B) with true positive and false positive IMLN groups.